Akèy › Ensifizyans kadyak › Nebraska › Omaha
Etid klinik pou Ensifizyans kadyak nan Omaha, NE
13 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Ap rekriteFaz 3
- Be Well Clinical Studies, Omaha
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Ap rekriteFaz 3
- University of Nebraska Medical Center, Omaha
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Ap rekrite
- University of Nebraska Medical Center, Omaha
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Ap rekriteFaz 3
- Research Site, Omaha
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Ap rekriteFaz 3
- CON-10018, Omaha, NE, Omaha
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Ap rekriteFaz 3
- Omaha, NE Investigative Site 10018, Omaha
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Ap rekrite
- University of Nebraska Medical Center, Omaha
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Ap rekriteEtid obsèvasyon
- Omaha, Omaha
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Ap rekriteEtid obsèvasyon
- CHI Health Reseach Center, Omaha
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Ap rekriteFaz 3
- Tenax Investigational Site, Omaha
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Ap rekrite
- University of Nebraska Medical Center, Omaha
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Ap rekrite
- University of Nebraska Medical Center, Omaha
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
Ap rekriteFaz 4
- Creighton University Medical Center, Omaha
Etid Ensifizyans kadyak nan lòt vil
- New York City, NY51 etid
- Boston, MA44 etid
- Dallas, TX42 etid
- Houston, TX36 etid
- Cleveland, OH33 etid
- Chicago, IL31 etid
- Philadelphia, PA31 etid
- San Francisco, CA29 etid
- St. Louis, MO26 etid
- Durham, NC26 etid
- Kansas City, MO25 etid
- Atlanta, GA25 etid
Lòt etid nan Omaha
- Kansè pwostat27 etid
- Kansè Poumon ki pa ti selil24 etid
- Kansè nan tete22 etid
- Kansè kolorektal18 etid
- Kansè (tout kalite)18 etid
- Myelom Miltip16 etid
- Limfòm Non-Hodgkin14 etid
- Kansè ovè14 etid
- Kansè pankreyas14 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Kansè Metastatik13 etid
- Kansè renn (Kasinom selil renn)12 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.